BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24855150)

  • 1. Alopecia and nail changes associated with voriconazole therapy.
    Malani AN; Kerr L; Obear J; Singal B; Kauffman CA
    Clin Infect Dis; 2014 Aug; 59(3):e61-5. PubMed ID: 24855150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole: alopecia and nail changes.
    Prescrire Int; 2015 Jan; 24(156):21. PubMed ID: 25729834
    [No Abstract]   [Full Text] [Related]  

  • 3. Voriconazole: How to Use This Antifungal Agent and What to Expect.
    Malani AN; Kerr LE; Kauffman CA
    Semin Respir Crit Care Med; 2015 Oct; 36(5):786-95. PubMed ID: 26398543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
    J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging screening to identify spinal and paraspinal infections associated with injections of contaminated methylprednisolone acetate.
    Malani AN; Vandenberg DM; Singal B; Kasotakis M; Koch S; Moudgal V; Jagarlamudi R; Neelakanta A; Otto MH; Halasyamani L; Kaakaji R; Kauffman CA
    JAMA; 2013 Jun; 309(23):2465-72. PubMed ID: 23780459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.
    Kerkering TM; Grifasi ML; Baffoe-Bonnie AW; Bansal E; Garner DC; Smith JA; Demicco DD; Schleupner CJ; Aldoghaither RA; Savaliya VA
    Ann Intern Med; 2013 Feb; 158(3):154-61. PubMed ID: 23183583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Shang W; Feng G; Sun R; Wang X; Liu W; Zhang S; Li J; Pang X; Wang Y; Zhang W
    J Clin Pharm Ther; 2012 Dec; 37(6):652-6. PubMed ID: 22725946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects.
    Jacobsen AA; Papo YB; Sarro R; Weisse K; Strasswimmer J
    JAMA Dermatol; 2016 Jul; 152(7):839-41. PubMed ID: 27007669
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH
    Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D; Buadi FK; McClune B
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of total skin electron beam therapy for mycosis fungoides on hair and nail loss and regrowth.
    Breneman DL; Breneman A; Ballman E; Breneman JC
    J Dermatolog Treat; 2022 Jun; 33(4):1975-1978. PubMed ID: 33755504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM;
    Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    Supparatpinyo K; Schlamm HT
    Am J Trop Med Hyg; 2007 Aug; 77(2):350-3. PubMed ID: 17690411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical and oral voriconazole in the treatment of fungal keratitis.
    Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ
    Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Lem J; Younus M; Aram JA; Moosavi S; Freivogel K; Lewis A; Sobel RE
    Pharmaceut Med; 2019 Apr; 33(2):121-133. PubMed ID: 31933256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort.
    Trubiano JA; Crowe A; Worth LJ; Thursky KA; Slavin MA
    J Antimicrob Chemother; 2015 Apr; 70(4):1161-5. PubMed ID: 25558073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
    Al-Badriyeh D; Slavin M; Liew D; Thursky K; Downey M; Grigg A; Bajel A; Stewart K; Kong DC
    J Antimicrob Chemother; 2010 May; 65(5):1052-61. PubMed ID: 20237074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.